Abstract
Intensive endurance training is able to cause a distinct pattern of functional and structural changes of the cardiovascular system. In an unknown proportion of athletes a so called “athlete’s heart” develops. There is an overlap between this type of physiologic cardiac hypertrophy and mild forms of hypertrophic cardiomyopathy (HCM), the most common genetic disorder of the cardiovascular system with a prevalence of 0.2%. HCM is caused by mutations in 14 genes coding for sarcomere proteins. In the literature up to 50% of cases of sudden cardiac death (SCD) in younger sportsmen were connected to hypertrophic cardiomyopathy. It is therefore the most common cause of SCD in highly trained young athletes. Because of this data a great interest in distinguishing these two diagnoses exists. Apart from clinical examination and some non-specific ECG-changes, Echocardiography is the method of choice. The athlete’s heart shows an eccentric biventricular hypertrophy with wall thicknesses under 15 mm and a moderately dilated left ventricle (LVEDD up to 58 mm). HCM is commonly characterized by asymmetric left ventricular hypertrophy with a reduced LV-diameter. In up to 70% of cases left ventricular outflow tract obstruction is evident during stress echocardiography. Systolic function is normal in highly trained athletes and the majority of HCM patients as well. There are important differences regarding diastolic filling patterns. Physiological hypertrophy is consistent with a normal diastolic function with even increased early diastolic filling. In case of HCM diastolic dysfunction (mostly relaxation disturbances) occurs in the majority of patients and is therefore inconsistent with an athlete’s heart. If the diagnosis could not be stated using echocardiography, methods like cardiac-MRI, metabolic exercise testing, histological studies of endomyocardial biopsies and genetic testing can provide further information. A correct diagnosis may on the one hand prevent some athletes from sudden cardiac death. On the other hand sportsmen with an athlete’s heart are reassured and able to continue as competitors. New insights into electrophysiological changes during physiological hypertrophy could probably change this view.
Similar content being viewed by others
References
Basavarajaiah S, Wilson M, Junagde S et al (2006) Physiological left ventricular hypertrophy or hypertrophic cardiomyopathy in an elite adolescent athlete: role of detraining in resolving the clinical dilemma. Br J Sports Med 40:727–729
Corrado D, Basso C, Rizzoli G et al (2003) Does sport activity enhance the risk of sudden cardiac death in adolescents and young adults? J Am Coll Cardiol 42:1959–1963
D’Andrea A, Caso P, Cuomo S et al (2006) Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes. Br J Sports Med 40:244–250
Dickhuth HH, Hipp A, Niess A et al (2001) Differenzialdiagnostik der physiologischen Herzhypertrophie (Sportherz). Dtsch Z Sportmed 6:205–210
Dickhuth HH, Lehmann M, Auch-Schwelk W et al (1987) Physical training, vegetative regulation and cardiac hypertrophy. J Cardiovasc Pharmacol 10(Suppl 6):71–78
Dickhuth HH, Röcker K, Mayer F et al (2004) Ausdauersport und kardiale Adaptation (Sportherz). Herz 29:373–380
Dickhuth HH, Röcker K, Niess A et al (1996) The echocardiographic determination of volume and muscle mass of the heart. Int J Sports Med 17(Suppl 3):132–139
Durakovic Z, Misigoj-Durakovic M, Medved R et al (2002) Sudden death due to physical exercise in the elderly. Coll Antropol 26:239–243
Elliott PM, Gimeno JR, Tomé MT et al (2006) Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 27:1933–1941
Firoozi S, Sharma S, McKenna WJ (2003) Risk of competitive sport in young athletes with heart disease. Heart 89:710–714
Hart G (2003) Exercise-induced cardiac hypertrophy: a substrate for sudden death in athletes? Exp Physiol 88:639–644
Kohl H, Powell K, Gordon N et al (1992) Physical activity, physical fitness and sudden cardiac death. Epidemiol Rev 14:37–58
Lie H, Mundal R, Erikssen J (1985) Coronary risk factors and incidence of coronary death in relation to physical fitness: seven-year-follow-up study of middle aged and elderly men. Eur Heart J 6:147–157
Maron BJ (1986) Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol 7:190–203. (abstract)
Maron BJ, Anan TJ, Roberts WC (1981) Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Ciculation 63:882–894
Maron BJ, Gardin JM, Flack JM et al (1995) Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. Circulation 92:785–789
Maron BJ, Gottdiener JS, Epstein SE (1981) Patterns and significance of the distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a widw angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 48:418–428
Maron BJ, Pelliccia A, Spirito P (1995) Cardiac disease in young trained athletes. Circulation 91:1596–1601
Maron BJ, Roberts WC (1979) Quantitative analysis of cardic muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 59:689–706
Maron BJ, Wolfson JK, Epstein SE et al (1986) Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8:545–557
Maron MS, Olivotto I, Zenovich et al (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114:2232–2239
Marti B, Goerre S, Spuhler T et al (1989) Plötzliche Todesfälle an Schweizer Volksläufen 1978–1987: eine epidemiologisch-pathologische Studie. Schweiz Med Wochenschr 119:473–482
Meyer K, Greinacher W, Weidemann H (1991) Koronarpatienten im Fitness-Studio–eine riskante Bewegungstherapie. Dtsch Z Sportmed 42:60–66
Nistri S, Olivotto I, Atocchi S et al (2006) Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian registry for hypertrophic cardiomyopathy). Am J Cardiol 98:960–965
Paulus WJ, Tschöpe C, Sanderson JE et al (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the European Society of Cardiology. Eur Heart J 28:2539–2550
Pelliccia A, Culasso F, Di Paolo FM, Maron BJ (1999) Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 130:23–31
Pluim BM, Zwinderman AH, Van der Laarse A et al (1999) The athlete’s heart: a meta-analysis of cardiac structure and function. Circulation 100:336–344
Scharhag J, Schneider G, Urhausen A et al (2002) Athlete’s heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol 10:1856–1863
Scheffold T, Binner P, Erdmann J et al (2005) Hypertrophe Kardiomyopathie. Herz 30:550–557
Schmidt-Trucksäss A, Schmid A, Häussler C et al (2001) Left ventricular wall motion during diastolic filling in endurance-trained athletes. Med Sci Sports Exerc 33(2):189–195
Shah PM, Gramiak R, Kramer DH (1969) Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy. Circulation 40:3–11
Scharhag J, Urhausen A, Schneider G et al (2003) Left ventricular mass in endurance-athletes with athlete′s heart and untrained subjects–comparison between different echocardiographic methods and MRI. Z Kardiol 92:309–318
Sharma S, Elliott PM, Whyte G et al (2000) Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. J Am Coll Cardiol 36:864–870
Sherrid MV, Mahenthiran J, Casteneda V et al (2006) Comparison of diastolic septal perforator flow velocities in hypertrophic cardiomyopathy versus hypertensive left ventricular hypertrophy. Am J Cardiol 97:106–112
St. John Sutton MG, Lie JT, Anderson KR et al (1980) Histopathological specifity of hypertrophic obstructive cardiomyopathy. Br Heart J 44:433–443
Van Driest SL, Ommen SR, Tajik AJ et al (2005) Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc 80:463–469
Wight JN Jr, Salem D (1995) Sudden cardiac death and the “athlete's heart”. Arch Int Med 14 (abstract)
Wigle ED, Sasson Z, Henderson MA et al (1985) Hypertrophic cardiomyopathy: the importance of the site and extent of hypertrophy: a review. Prog Cardiovsc Dis 28:1–83
Wigle ED (2001) The diagnosis of hypertrophic cardiomyopathy. Heart 86:709–714
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lauschke, J., Maisch, B. Athlete’s heart or hypertrophic cardiomyopathy?. Clin Res Cardiol 98, 80–88 (2009). https://doi.org/10.1007/s00392-008-0721-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-008-0721-2